Avise Health vs PointClickCare

Side-by-side comparison of AI visibility scores, market position, and capabilities

PointClickCare leads in AI visibility (93 vs 41)
Avise Health logo

Avise Health

EmergingHealthcare

Autoimmune Diagnostics

Avise provides specialized diagnostic tests for autoimmune diseases including lupus and rheumatoid arthritis that help rheumatologists make faster and more accurate diagnoses.

AI VisibilityBeta
Overall Score
C41
Category Rank
#1 of 1
AI Consensus
51%
Trend
up
Per Platform
ChatGPT
33
Perplexity
43
Gemini
52

About

Avise Medical is a specialty diagnostics company founded in 2012 that develops laboratory tests specifically designed to help rheumatologists diagnose and monitor autoimmune diseases including lupus, rheumatoid arthritis, and related conditions. The company's flagship products include AVISE Lupus, a panel of blood biomarkers that increases diagnostic accuracy for systemic lupus erythematosus compared to traditional single-marker tests, and AVISE CTD for connective tissue disease diagnosis. Autoimmune diseases are notoriously difficult to diagnose because symptoms overlap with many other conditions and individual biomarkers have limited sensitivity and specificity. Avise addresses this through multi-biomarker panels that use machine learning to combine signals into diagnostic scores with better performance characteristics. The company works directly with rheumatology practices and provides specialized clinical interpretation support for complex cases. Avise raised over $100M and expanded its diagnostic portfolio to cover monitoring of disease activity and treatment response in addition to initial diagnosis. The company represents the application of advanced biomarker discovery and machine learning to specialty diagnostics in rheumatology.

Full profile
PointClickCare logo

PointClickCare

LeaderSenior Care Tech

Long-Term Care Platform

Cloud-based EHR and care coordination platform for long-term and post-acute care organizations. Mississauga, Canada. Raised $172M+, unicorn. Serves 27,000+ care facilities across North America.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 1
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
88
Perplexity
99
Gemini
99

About

PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the company has raised over $172 million and achieved unicorn valuation status. PointClickCare serves over 27,000 care facilities including skilled nursing facilities, senior living communities, assisted living centers, and home health agencies across the United States and Canada. The platform provides electronic health records (EHR), billing, care coordination, and business intelligence capabilities.\n\nPointClickCare's platform is built around the complex clinical and regulatory workflows unique to post-acute care, which differ substantially from acute hospital EHR requirements. The system manages MDS assessments, care planning, medication administration records, therapy documentation, and the complex billing requirements for Medicare, Medicaid, and managed care payers. Its network effect is significant — because PointClickCare connects so many facilities, care transitions between hospitals and post-acute settings can be managed with streamlined data exchange.\n\nThe company has expanded through strategic acquisitions including Collective Medical, which added care transition and high-risk patient identification capabilities powered by a large hospital and payer data network. PointClickCare's Marketplace ecosystem allows third-party technology vendors to integrate with the platform, creating an app store model that extends its functionality without requiring PointClickCare to build every adjacent capability. As value-based care models push accountable care organizations to manage patient outcomes across the full episode of care, PointClickCare's position at the post-acute node of the care continuum becomes increasingly strategically important.

Full profile

AI Visibility Head-to-Head

41
Overall Score
93
#1
Category Rank
#1
51
AI Consensus
68
up
Trend
up
33
ChatGPT
88
43
Perplexity
99
52
Gemini
99
32
Claude
99
42
Grok
91

Key Details

Category
Autoimmune Diagnostics
Long-Term Care Platform
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Avise Health
Autoimmune Diagnostics
Only PointClickCare
Long-Term Care Platform

Integrations

Only PointClickCare

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.